For a drug that a lot of people have never heard of, kratom has gotten a lot of press coverage lately. Last week, the United States Food and Drug Administration announced a mandatory recall of all kratom products from one distributor following a rash of reports from the Centers for Disease Control and Prevention that a multi-state Salmonella outbreak linked to kratom has sickened 132 people in 38 states. While there is reason for concern, it’s important to attribute it to the right factors. A closer look at the situation and the scientific literature on kratom reveals there’s a lot more to it than current alarmist headlines suggest.

Used for centuries in Southeast Asia medicinally and recreationally, the herbal drug, which is known for effects like stimulation and pain relief, sedation, and euphoria, has recently also become popular in the U.S. for medical and recreational reasons. Almost as quickly, state and federal regulators have moved to restrict access to it: In 2016, the Drug Enforcement Administration tried to ban kratom in order to “avoid an imminent hazard to public safety,” citing the drug’s opioid-like high that occurs at higher doses. The DEA’s efforts stalled, and in February, the Food and Drug Administration announced that it would make moves to restrict access to kratom. The CDC announcements about Salmonella-tainted kratom have underscored the potential dangers of taking the drug.

But Salmonella infection is one thing we are certain is dangerous; the safety of kratom itself is a different and open question, as research on it is sparse. Here’s what we actually know.